financetom
Business
financetom
/
Business
/
Blueprint Medicines Insider Sold Shares Worth $3,905,872, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blueprint Medicines Insider Sold Shares Worth $3,905,872, According to a Recent SEC Filing
Aug 7, 2024 2:26 PM

05:13 PM EDT, 08/07/2024 (MT Newswires) -- Philina Lee, Chief Commercial Officer, on August 05, 2024, sold 41,913 shares in Blueprint Medicines ( BPMC ) for $3,905,872. Following the Form 4 filing with the SEC, Lee has control over a total of 34,729 shares of the company, with 34,729 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1597264/000141588924020928/xslF345X03/form4-08072024_090858.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dayforce Expands Microsoft Collaboration to Streamline Workflows With AI Agents
Dayforce Expands Microsoft Collaboration to Streamline Workflows With AI Agents
Oct 7, 2025
04:31 PM EDT, 10/07/2025 (MT Newswires) -- Dayforce ( DAY ) after trade Tuesday said it expanded its collaboration with Microsoft (MSFT) to embed Dayforce AI Agents directly into tools like Teams and Copilot Studio, allowing employees to interact with human resources (HR) and payroll data inside familiar workflows. The company also introduced Strategic Workforce Planning, a new tool designed...
Peru minister touts Saudi mining interest and Chevron offshore potential
Peru minister touts Saudi mining interest and Chevron offshore potential
Oct 7, 2025
SANTIAGO, Oct 7 (Reuters) - Peru's Minister of Energy and Mines Jorge Luis Montero said on Tuesday he expects the country to sign a Memorandum of Understanding (MOU) with Saudi Arabia in November to develop lithium, copper and other strategic mineral projects in the Andean nation. In an interview with Reuters, Montero also said that offshore oil lots being explored...
Stoke Therapeutics Insider Sold Shares Worth $1,065,206, According to a Recent SEC Filing
Stoke Therapeutics Insider Sold Shares Worth $1,065,206, According to a Recent SEC Filing
Oct 7, 2025
04:32 PM EDT, 10/07/2025 (MT Newswires) -- Edward M. Kaye, Director, on October 03, 2025, sold 42,461 shares in Stoke Therapeutics ( STOK ) for $1,065,206. Following the Form 4 filing with the SEC, Kaye has control over a total of 49,124 common shares of the company, with 49,124 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1623526/000152278025000004/xslF345X05/form4-10072025_081055.xml ...
Veracyte Insider Sold Shares Worth $300,709, According to a Recent SEC Filing
Veracyte Insider Sold Shares Worth $300,709, According to a Recent SEC Filing
Oct 7, 2025
04:32 PM EDT, 10/07/2025 (MT Newswires) -- Phillip G. Febbo, Chief Scientific & Medical Officer, on October 06, 2025, sold 8,349 shares in Veracyte ( VCYT ) for $300,709. Following the Form 4 filing with the SEC, Febbo has control over a total of 92,441 common shares of the company, with 92,441 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1384101/000164924525000005/xslF345X05/wk-form4_1759868872.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved